Compare Mutual Funds

Pros

-

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

-

INDMoney rank
-
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

1 Years 3 Months

13 Years 5 Months

Fund AUM

₹315 Cr

₹8306 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹500
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.74%

0.91%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

39

39

Top 5 Holdings
  1. Divi's Laboratories Ltd(9.21%)
  2. Sun Pharmaceuticals Industries Ltd(8.4%)
  3. Apollo Hospitals Enterprise Ltd(6.8%)
  4. Piramal Pharma Ltd(6.21%)
  5. Aurobindo Pharma Ltd(5.93%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

5

1

Top 3 Sectors
  1. Health(89.06%)
  2. Corporate(27.34%)
  3. Government(8.66%)

Health

(100%)

Equity %

97.53%

99.7%

Debt %

0.35%

-

P/E

43.5

35.73

P/B

5.76

5.7

Credit Quality

-

-

Modified Duration

0.44

-

YTM

6.39

-

1-Month Return

-2.89%

-2.91%

3-Month Return

-4.13%

-1.77%

6-Month Return

-3.59%

-1.1%

1-Year Return

3.1%

3.24%

3-Year Return

-

24.53%

5-Year Return

-

16.64%

Sharpe

-

1.17

Alpha

-

0.22

Beta

-

0.9

Standard Deviation

-

15.21

Information Ratio

-

-0.47

Description

Bajaj Finserv Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sorbh Gupta, Nimesh Chandan, Siddharth Chaudhary

Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma

Most Popular Comparisons